Introduction
Tg2576 transgenic mice overexpress the Swedish mutation of the human amyloid precursor protein (APP) gene and are a widely employed model of aberrant amyloid deposition in Alzheimer's disease (AD). Tg2576 mice exhibit progressive increases in soluble and fibrillar Aβ peptides and deposits in the brain, resulting in neuropathological alterations and behavioral deficits reminiscent of AD (Hsiao, 1998) . In these mice, high levels of soluble Aβ species are present by 6 months of age and fibrillar plaque deposition first appears at about 11-12 months of age (Kawarabayashi et al., 2001; Lehman et al., 2003) . Numerous studies have established that proximity to fibrillar Aβ plaques is associated with dystrophic dendrites and axons, aberrant sprouting and increased curvature of dendritic processes and dramatic reductions in dendritic spine density with accompanying synapse loss in hippocampal and neocortical pyramidal cells (Knowles et al., 1999; Urbanc et al., 2002; Tsai et al., 2004; Spires et al., 2005; Meyer-Luehmann et al., 2008; review: Spires and Hyman, 2004) . Less is known about the effect of endogenous soluble Aβ species on neuronal morphology in younger Tg2576 mice prior to substantial fibrillar plaque deposition, nor about the effects of Aβ on global dendritic morphology of entire cells.
It has long been hypothesized that Aβ-induced morphological changes in a given cell lead to functionally relevant alterations in electrophysiological properties, because morphology is a fundamental determinant of synaptic integration and neural firing patterns (Mainen and Sejnowski, 1996; Euler and Denk, 2001; Krichmar et al., 2002; Vetter et al., 2001 ). The dramatic reduction in density of dendritic spines (the principal postsynaptic substrate for glutamatergic inputs) might plausibly lead to significant reductions in excitatory synaptic responses. Indeed, a number of studies have shown that both exogenous and endogenous Aβ significantly reduce glutamatergic synaptic responses in the hippocampus (review: Walsh and Selkoe, 2004; Jacobsen et al, 2006; Venkitaramani et al., 2007; Parameshwaran et al., 2008) . Interestingly, there is evidence that the effects of Aβ on glutamatergic synaptic signaling may be more prominent in the hippocampus than elsewhere in the brain. For example, in vivo studies have shown that glutamatergic synaptic transmission is unaltered in the neocortex of APP mutant mice at a young age (Roder et al., 2003; Stern et al., 2004) , even while it is impaired in the hippocampus of the same subjects (Roder et al., 2003) . While the previous identifications of structural changes are important, they cannot be used to make definitive conclusions about the functionality of a given cell in the absence of empirical evidence. The question of the relationship between structure and function of Neurobiology of Disease 32 (2008) 309-318 
